Besides, genetic factors (e.g., genes in the epidermal growth factor receptor pathway) may also contribute to the racial differences that may be linked with better prognosis in non‐Hispanic white NPC patients, although the definitive associations between those genetic changes and race have not been established 31. This evidence concerns the gene EGFR and nasopharyngeal carcinoma.